Cargando…

Nanocrystal technology, drug delivery and clinical applications

Nanotechnology will affect our lives tremendously over the next decade in very different fields, including medicine and pharmacy. Transfer of materials into the nanodimension changes their physical properties which were used in pharmaceutics to develop a new innovative formulation principle for poor...

Descripción completa

Detalles Bibliográficos
Autores principales: Junghanns, Jens-Uwe A H, Müller, Rainer H
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2626933/
https://www.ncbi.nlm.nih.gov/pubmed/18990939
_version_ 1782163498895147008
author Junghanns, Jens-Uwe A H
Müller, Rainer H
author_facet Junghanns, Jens-Uwe A H
Müller, Rainer H
author_sort Junghanns, Jens-Uwe A H
collection PubMed
description Nanotechnology will affect our lives tremendously over the next decade in very different fields, including medicine and pharmacy. Transfer of materials into the nanodimension changes their physical properties which were used in pharmaceutics to develop a new innovative formulation principle for poorly soluble drugs: the drug nanocrystals. The drug nanocrystals do not belong to the future; the first products are already on the market. The industrially relevant production technologies, pearl milling and high pressure homogenization, are reviewed. The physics behind the drug nanocrystals and changes of their physical properties are discussed. The marketed products are presented and the special physical effects of nanocrystals explained which are utilized in each market product. Examples of products in the development pipelines (clinical phases) are presented and the benefits for in vivo administration of drug nanocrystals are summarized in an overview.
format Text
id pubmed-2626933
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-26269332009-02-18 Nanocrystal technology, drug delivery and clinical applications Junghanns, Jens-Uwe A H Müller, Rainer H Int J Nanomedicine Reviews Nanotechnology will affect our lives tremendously over the next decade in very different fields, including medicine and pharmacy. Transfer of materials into the nanodimension changes their physical properties which were used in pharmaceutics to develop a new innovative formulation principle for poorly soluble drugs: the drug nanocrystals. The drug nanocrystals do not belong to the future; the first products are already on the market. The industrially relevant production technologies, pearl milling and high pressure homogenization, are reviewed. The physics behind the drug nanocrystals and changes of their physical properties are discussed. The marketed products are presented and the special physical effects of nanocrystals explained which are utilized in each market product. Examples of products in the development pipelines (clinical phases) are presented and the benefits for in vivo administration of drug nanocrystals are summarized in an overview. Dove Medical Press 2008-09 /pmc/articles/PMC2626933/ /pubmed/18990939 Text en © 2008 Dove Medical Press Limited. All rights reserved
spellingShingle Reviews
Junghanns, Jens-Uwe A H
Müller, Rainer H
Nanocrystal technology, drug delivery and clinical applications
title Nanocrystal technology, drug delivery and clinical applications
title_full Nanocrystal technology, drug delivery and clinical applications
title_fullStr Nanocrystal technology, drug delivery and clinical applications
title_full_unstemmed Nanocrystal technology, drug delivery and clinical applications
title_short Nanocrystal technology, drug delivery and clinical applications
title_sort nanocrystal technology, drug delivery and clinical applications
topic Reviews
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2626933/
https://www.ncbi.nlm.nih.gov/pubmed/18990939
work_keys_str_mv AT junghannsjensuweah nanocrystaltechnologydrugdeliveryandclinicalapplications
AT mullerrainerh nanocrystaltechnologydrugdeliveryandclinicalapplications